The Medical Capital is a leading biomedical location and a hotbed of global health innovation.
It capitalizes on a vibrant biomedical industry with 700+ companies (including Charles River Labs, Medtronic and IBM Watson Health) and world-renowned clinical, research and education institutions such as Cleveland Clinic, Case Western Reserve University, University Hospitals and many others.
It covers an 18-county Northeast Ohio region, centered in Cleveland. Qmed recently named Cleveland as one of the top 10 cities in the U.S. for medtech innovation.
The Medical Capital companies have attracted over $2 billion in growth capital since 2003 from 88 national investors, and 32 Cleveland-area biomedical investors – with more than 56 exits in the same period.
Investors find high-value opportunities in The Medical Capital, through both startup and established companies, that leverage leading-edge technologies in cardiovascular therapy (link), biomaterials (link), health IT (link), neurostimulation (link), medical imaging (link), regenerative medicine (link), and other key sectors.
The Medical Capital has the critical entrepreneurial resources to speed an idea from bench to bedside, including: internationally recognized clinical and research collaborations, access to diverse patient populations, multiple funding sources, and biomedical business accelerators, incubators and entrepreneurial support organizations.
The Medical Capital is a prime location to begin or advance your biomedical career in a diverse array of lifescience companies and health institutions.
The Medical Capital initiative is a collaborative effort involving the institutions, organizations and accelerators that make Northeast Ohio a center of healthcare excellence.